|
Volumn 52, Issue 2-3, 1992, Pages 135-138
|
Fibrinolytic activity in women on oral contraceptive pills: Variation due to haemoglobin genotype
a a a |
Author keywords
Contraception; Fibrinolytic activity; Hemoglobin AA, AS; Oral contraceptive pill
|
Indexed keywords
FIBRINOGEN;
ORAL CONTRACEPTIVE AGENT;
UNCLASSIFIED DRUG;
ADULT;
ARTICLE;
CONTROLLED STUDY;
FEMALE;
FIBRINOLYSIS;
GENOTYPE;
HEMOGLOBIN AA;
HEMOGLOBIN AS;
HUMAN;
HUMAN TISSUE;
MAJOR CLINICAL STUDY;
ORAL DRUG ADMINISTRATION;
PLASMA;
RISK FACTOR;
THROMBOEMBOLISM;
AFRICA;
AFRICA SOUTH OF THE SAHARA;
BIOLOGY;
BLOOD COAGULATION EFFECTS;
CONTRACEPTION;
CONTRACEPTIVE METHODS;
DEVELOPING COUNTRIES;
DISEASES;
EMBOLISM;
ENGLISH SPEAKING AFRICA;
FAMILY PLANNING;
FIBRINOLYSIS;
GENETICS;
HEMATOLOGICAL EFFECTS;
HEMIC SYSTEM;
NIGERIA;
ORAL CONTRACEPTIVES;
PHYSIOLOGY;
RESEARCH REPORT;
RISK FACTORS;
THROMBOEMBOLISM;
VASCULAR DISEASES;
WESTERN AFRICA;
ADOLESCENT;
ADULT;
COMPARATIVE STUDY;
CONTRACEPTIVES, ORAL;
FEMALE;
FIBRINOGEN;
FIBRINOLYSIS;
GENOTYPE;
HEMOGLOBIN A;
HEMOGLOBIN, SICKLE;
HUMAN;
RISK FACTORS;
SUPPORT, NON-U.S. GOV'T;
|
EID: 0027085940
PISSN: 0001706X
EISSN: None
Source Type: Journal
DOI: 10.1016/0001-706X(92)90029-W Document Type: Article |
Times cited : (3)
|
References (8)
|